CClinicalTrials.gg
CompletedNCT03966196OXYMETREUpdated May 29, 2019

Validation and Characterization of Signal Decrease on an Oximeter in COPD (They Have Chronic Obstructive Pulmonary Disease) Patients During Deep Inhalation (

An interventional study of Measurements of oxygen saturation and finger pressure during deep inspiration in Pulmonary Disease and Copd, sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Completed at 1 site in Belgium. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-05-29.

Sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Feb 2019, registered May 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The objective is to verify that there is a decrease in the pulsed oxygen saturation with the digital sensor. That is, the drop in oxygen saturation in COPD patients during inhalation is real and not due to an artifact of the measuring tool, because oximeters need a quality pulsatile signal to properly measure oxygen saturation

02

Conditions studied

03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 12 is below the median of 72 across 2,118 interventional studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the lead sponsor of 342 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

healthy arm

Inclusion Criteria:

  • Healthy adults volunteers are recruited from students with normal lung function.

Exclusion Criteria:

  • abnormal lung function

COPD Arm

Inclusion Criteria:

  • Adults with Chronic Obstructive pulmonary disease

Exclusion Criteria:

  • cardiovascular disease

The subjects selected are selected on a voluntary basis among the patients coming to the pulmonary consultation. They have Chronic Obstructive Pulmonary Disease.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Other
    Healthy Volunteers

    oxymetry and finger pressure in Healthy subjects

    Other: Measurements of oxygen saturation and finger pressure during deep inspiration

  • Experimental
    COPD patients

    oxymetry and finger pressure in COPD patients

    Other: Measurements of oxygen saturation and finger pressure during deep inspiration

Interventions

  • OtherMeasurements of oxygen saturation and finger pressure during deep inspiration

    Measurements during deep inspiration of oxygen saturation with pulse oximeter and finger pressure with pressure cuff

06

What researchers measure

Primary outcomes

  1. drop in oxygen saturation during deep inspiration in COPD

    saturation is measured in percentage (SPO2)

    Time frame: from the intervention to 3 minutes after the start of the intervention

07

Study locations

1 site
  • Cliniques universitaires Saint-Luc
    Brussels, 1200, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 29, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03966196
Lead sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Responsible party
Sponsor
First posted
May 29, 2019
Start date
Feb 11, 2019
Primary completion
May 10, 2019
Completion
May 10, 2019
Last update
May 29, 2019

Study contacts

Giuseppe Liistro, PhD, MD
principal investigator · Cliniques universitaires Saint-Luc

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion